Results 161 to 170 of about 15,817,770 (195)
Some of the next articles are maybe not open access.
Biochemical Pharmacology, 1990
S-Adenosylhomocysteine hydrolase has been recognized as the target enzyme for the antiviral activity of several carbocyclic and acyclic adenosine analogues. In a previous study [Cools M and De Clercq E, Biochem Pharmacol 38: 1061-1067, 1989], we found a close correlation between the antiviral activity of six adenosine analogues [S)-9-(2,3 ...
M, Cools, E, De Clercq
openaire +2 more sources
S-Adenosylhomocysteine hydrolase has been recognized as the target enzyme for the antiviral activity of several carbocyclic and acyclic adenosine analogues. In a previous study [Cools M and De Clercq E, Biochem Pharmacol 38: 1061-1067, 1989], we found a close correlation between the antiviral activity of six adenosine analogues [S)-9-(2,3 ...
M, Cools, E, De Clercq
openaire +2 more sources
Microsomal phosphatidylethanolamine methyltransferase: Inhibition by S‐adenosylhomocysteine
Lipids, 1981AbstractInhibition by S‐adenosylhomocysteine (AdoHcy) of the three reactions of phosphatidylethanolamine methyltransferase which catalyzes the production of phosphatidylcholine from phosphatidyl‐ethanolamine in guinea pig and rat liver microsomes has been evaluated. Five of the six methylation reactions in these two species exhibit greater affinity for
D R, Hoffman +2 more
openaire +2 more sources
Inhibition of indolethylamine-N-methyltransferase by S-Adenosylhomocysteine
Biochemical and Biophysical Research Communications, 1973Abstract S -Adenosylhomocysteine (SAH) is a potent product inhibitor for indoleamine- N -methyltransferase (INMT) from rabbit lung. The kinetic studies showed that this inhibition was competitive with respect to S -adenosylmethionine (SAM) and noncompetitive with respect to N -methylserotonin (NMS). The K i value of 1.0 ×
R L, Lin +2 more
openaire +2 more sources
Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase
Bioorganic & Medicinal Chemistry Letters, 2014Elevated plasma homocysteine (Hcy) levels are an independent risk factor for the onset and progression of Alzheimer's disease. Reduction of Hcy to normal levels therefore presents a new approach for disease modification. Hcy is produced by the cytosolic enzyme S-adenosylhomocysteine hydrolase (AHCY), which converts S-adenosylhomocysteine (SAH) to Hcy ...
Antonella, Converso +15 more
openaire +2 more sources
Contribution of S-adenosylhomocysteine to cardiac adenosine formation
Journal of Molecular and Cellular Cardiology, 1989The S-adenosylhomocysteine (SAH) hydrolase inhibitor adenosine dialdehyde was used in isolated guinea pig hearts to determine the contribution of the transmethylation pathway to cardiac adenosine formation. This inhibitor did not alter cardiac hemodynamics but effectively inhibited SAH-hydrolase activity under in vitro and in vivo conditions.
A, Deussen, H G, Lloyd, J, Schrader
openaire +2 more sources
S-Adenosylhomocysteine Assay in the Urine by Capillary Electrophoresis
Bulletin of Experimental Biology and Medicine, 2015We present a simple and effective method for measuring urine S-adenosylhomocysteine by capillary electrophoresis without using modifiers. The detection threshold of the method is 0.1 μM S-adenosylhomocysteine, the time of analysis 13 min, reproducibility at physiological concentrations within 4%.
B P, Luzyanin +3 more
openaire +2 more sources
Molecular Pharmacology, 1984
The aliphatic adenine analogues, D-eritadenine, L-eritadenine, L-threoeritadenine, and 9-(S)-(2,3-dihydroxypropyl)adenine [(S)DHPA] function as inhibitors/inactivators of purified S-adenosylhomocysteine (AdoHcy) hydrolase, but these compounds did not induce reduction of enzyme-bound NAD+.
J S, Schanche +4 more
openaire +2 more sources
The aliphatic adenine analogues, D-eritadenine, L-eritadenine, L-threoeritadenine, and 9-(S)-(2,3-dihydroxypropyl)adenine [(S)DHPA] function as inhibitors/inactivators of purified S-adenosylhomocysteine (AdoHcy) hydrolase, but these compounds did not induce reduction of enzyme-bound NAD+.
J S, Schanche +4 more
openaire +2 more sources
S-Adenosylhomocysteine hydrolase activity in human myocardium
Cardiovascular Research, 1992Measurement of S-adenosylhomocysteine (SAH) accumulation in the heart reflects the concentration of free cytosolic adenosine and is thus a sensitive indicator of regional myocardial ischaemia. To evaluate the possibility of applying this method in combination with 11C-SAH positron emission tomography (PET) to patients with ischaemic heart disease the ...
M M, Borst, A, Deussen, J, Schrader
openaire +2 more sources
Applied Microbiology and Biotechnology, 2011
Recombinant S-adenosylhomocysteine hydrolase from Corynebacterium glutamicum (CgSAHase) was covalently bound to Eupergit® C. The maximum yield of bound protein was 91% and the catalytic efficiency was 96.9%. When the kinetic results for the immobilized enzyme were compared with those for the soluble enzyme, no decrease in the catalytic efficiency of ...
J D, Lozada-Ramírez +2 more
openaire +2 more sources
Recombinant S-adenosylhomocysteine hydrolase from Corynebacterium glutamicum (CgSAHase) was covalently bound to Eupergit® C. The maximum yield of bound protein was 91% and the catalytic efficiency was 96.9%. When the kinetic results for the immobilized enzyme were compared with those for the soluble enzyme, no decrease in the catalytic efficiency of ...
J D, Lozada-Ramírez +2 more
openaire +2 more sources
S-Adenosylhomocysteine hydrolase deficiency
2008S-Adenosylhomocysteine hydrolase (AdoHcy) deficiency is a disorder in methionine metabolism. The enzyme catalyzes the hydrolysis of S-adenosylhomocysteine to homocysteine and adenosine. Its deficiency in human was first reported in 2003. Since then few other patients have been identified.
Ćuk, Mario +3 more
openaire +2 more sources

